Trial Profile
Open-label Pharmakokinetic Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg Intravenous Infusion to Patients With Inflammatory Bowel Disease (PK-IBD-02)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacokinetics
- Sponsors Pharmacosmos
- 15 Jan 2015 New trial record